0000899243-18-026470.txt : 20181009 0000899243-18-026470.hdr.sgml : 20181009 20181009201003 ACCESSION NUMBER: 0000899243-18-026470 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181006 FILED AS OF DATE: 20181009 DATE AS OF CHANGE: 20181009 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Louks Ronald Allen CENTRAL INDEX KEY: 0001706849 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37792 FILM NUMBER: 181114723 MAIL ADDRESS: STREET 1: C/O NANTHEALTH, INC. STREET 2: 9920 JEFFERSON BLVD. CITY: CULVER CITY STATE: CA ZIP: 90232 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NantHealth, Inc. CENTRAL INDEX KEY: 0001566469 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 273019889 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9920 JEFFERSON BLVD CITY: CULVER CITY STATE: CA ZIP: 90232 BUSINESS PHONE: (310) 853-7513 MAIL ADDRESS: STREET 1: 9920 JEFFERSON BLVD CITY: CULVER CITY STATE: CA ZIP: 90232 FORMER COMPANY: FORMER CONFORMED NAME: Nant Health, LLC DATE OF NAME CHANGE: 20130108 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-10-06 0 0001566469 NantHealth, Inc. NH 0001706849 Louks Ronald Allen C/O NANTHEALTH, INC. 9920 JEFFERSON BLVD. CULVER CITY CA 90232 1 1 0 0 See Remarks Common Stock 2018-10-06 4 M 0 10000 A 177391 D Common Stock 2018-10-06 4 F 0 3696 1.42 D 173695 D Common Stock 2018-10-06 4 S 0 6304 1.42 D 167391 D Restricted Stock Units 2018-10-06 4 M 0 10000 0.00 D Common Stock 10000 0 D Each restricted stock unit ("RSU") is the economic equivalent of one share of NantHealth, Inc. common stock. Subject to the Reporting Person's continuing to be a service provider (as defined in the 2016 Equity Incentive Plan) through each applicable vesting date, 40,000 RSUs vested on October 6, 2017, with the remaining 120,000 RSUs to vest monthly in equal amounts for 12 months, beginning on November 6, 2017. Upon vesting, the issuer will withhold shares sufficient to satisfy tax withholding obligations; the issuer will then be responsible for remitting a cash payment for the related withholding taxes; and the issuer will issue to the Reporting Person a net lower number of shares. In addition, upon vesting, the issuer and the Reporting Person have agreed that the issuer will repurchase the remaining shares at the then current market value. Pursuant to the terms of the grant, due to the vesting date occurring on a Saturday, the Issuer repurchased the shares at a price per share equal to the closing price on October 5, 2018. Chief Operating Officer & Director /s/ Brandon Villery, as Attorney-in-Fact 2018-10-09